Studies 437 and 438 Integrated 0-48 WeeksGrade 1-4 Treatment-Related Adverse Eventsa

PLB ADV 10

(n=228) (n=294)

Asthenia 14% 13%

Abdominal pain 11% 9%

Headache 10% 9%

Nausea 8% 5%

Flatulence 4% 4%

Diarrhea 4% 3%

Dyspepsia 2% 3%

aObserved in ? 3% of ADV treated patients

Previous slide

Next slide

Back to first slide

View graphic version